3169 results for «318»

Filter By

3169 results

EAPCI Fellows Course - Opening

15 May 2017 – From EuroPCR 2017

Welcome to the European Interventional Cardiology Fellows Course - Opening, consult this session if you want to find out more about the course hosted by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on Monday 15 and Tuesday morning 16 May.

These presentations were part of the EAPCI...

European Interventional Cardiology Fellows Course 2017

AsiaPCR/SingLIVE 2018: Closing Ceremony and Awards

27 Jan 2018 – From AsiaPCR/SingLIVE 2018

Join U. Kaul, T.H. Koh and S.T. Lim for the AsiaPCR/SingLIVE 2018 Closing Ceremony if you want to find out who this year's Best Abstract and Best Clinical case award winners are?

AsiaPCR/SingLIVE 2018: Closing Ceremony and Awards

PCR London Valves 2017 Opening Ceremony - Welcome address

25 Sep 2017 – From PCR London Valves 2017

PCR London Valves 2017

Welcome to Imaging Day

24 Sep 2017 – From PCR London Valves 2017

Welcome and introduction to PCR Innovators Day London

24 Sep 2017 – From PCR Innovators Day 2017

PCR Tokyo Valves 2018: Opening ceremony

31 Mar 2018 – From PCR Tokyo Valves 2018

Consult this session of the PCR Tokyo Valves 2018 opening ceremony and discover a continuum of educational projects in interventional cardiology.

PCR Tokyo Valves 2018: Closing ceremony and Awards

01 Apr 2018 – From PCR Tokyo Valves 2018

Consult this session of the PCR Tokyo Valves 2018 Closing ceremony and find out who the Best abstract winners are.

PCR Tokyo Valves 2018: Closing ceremony and Awards

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?